LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
Agreement signedPublished 17 Jun 2026

Sun Pharma USA /
Organon &

Sun Pharma USA agreed to buy Organon in a deal valued at $14.00 per share in cash

Buy side: Sun Pharma USA
Buy sideSun Pharma USA
Target: Organon &
TargetOrganon &
Organon & Co. · 17 Jun 2026Source
See the source
Follow Sun Pharma USA Follow Organon &
Buy side: Sun Pharma USA
Buy sideSun Pharma USA
Target: Organon &
TargetOrganon &
01 / BuyerSun Pharma USA
02 / TargetOrganon &
Source for the buyer and target: Organon & Co.

For the buyer and target.

“Subject to the terms and conditions of the Merger Agreement and in accordance with the DGCL, at the date and time when the certificate of merger has been executed and filed or at such later time agreed by the parties in writing and specified in the certificate of merger so executed and filed (such date and time, as applicable, the “Effective Time”), Merger Sub will be merged with and into Organon with Organon continuing as the Surviving Corporation and as a wholly owned subsidiary of Sun Pharma USA.”

Published 17 Jun 2026

Open the source
01

What happened

Under the merger agreement, each eligible Organon share would be converted into the right to receive $14.00 in cash, and Organon's equity awards would be cancelled for cash payments. Sun Pharma committed to a $1 billion funding commitment under the agreement. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Organon & Co.

Sun Pharma USA agreed to buy Organon in a deal valued at $14.00 per share in cash

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Organon & Co.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealSun Pharma USA / Organon &Agreement signed · Published 17 Jun 2026
BuyerSun Pharma USATargetOrganon &
This dealSun Pharma USA / Organon &

Agreement signed · Sun Pharma USA agreed to acquire Organon & (Agreement signed, published 17 Jun 2026).

Published 17 Jun 2026
Timeline
  1. Published by Organon & Co.
Hover or tap a name to see how it connects, and when
Deal Web as a list
  • Sun Pharma USA (Buyer) agreed to acquire this deal. Sun Pharma USA: 1 deal on Carrywatch.
  • Organon & (Target) target this deal. Organon &: 1 deal on Carrywatch.